Overview
As sweeping policy shifts unfold under the second Trump administration, Asia’s biotech and medtech sectors are facing a new wave of geopolitical and regulatory uncertainty. How will these developments impact innovation, market expansion, and compliance across the region? And how can Asia-based companies future-proof their go-to-market strategies in an increasingly volatile global landscape?
đź“ŁÂ Join Us for a Timely Industry Dialogue
As sweeping policy shifts unfold under the second Trump administration, Asia’s biotech and medtech sectors are facing a new wave of geopolitical and regulatory uncertainty. How will these developments impact innovation, market expansion, and compliance across the region? And how can Asia-based companies future-proof their go-to-market strategies in an increasingly volatile global landscape?
Biotech Connection Singapore (BCS), in collaboration with APACMed and Geneo at Singapore Science Park, is proud to present a panel discussion and networking event exploring these critical questions.
Decoding Trump 2.0: The Global Ripple Effect on Biotech and Medtech in Asia
đź—“Â Date:Â Tuesday, 20 May 2025
🕔 Time: 5:00 – 8:00 PM
đź“ŤÂ Venue:Â Metro @Â Â Bridge+, 2 Science Park Drive, Ascent, Level 1, Singapore 118222
🎤 Opening Speaker & Panel Moderator:
Sejal Mistry – Director, Crowell Global Advisors
💡 Panel Speakers:
Stephen Lim – CEO, FathomX
Vishal Doshi – Founder & CEO, AUM Biosciences
Michael Ma – CEO, MedAsian Group
🤝 Don’t miss this opportunity to connect with industry leaders and explore how Asia’s biotech and medtech players are adapting and thriving in a rapidly evolving global landscape.
Schedule
Date: 20 May 2025, Tuesday
Time: 5:00 PM - 8:00 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: Metro @ Bridge+, 2 Science Park Drive, Ascent, Level 1, Singapore , 118222
